AIM
BNR

ARK Investment Management’s Burning Rock Biotech BNR Stock Holding History

ARK Investment Management’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-177,272
Closed -$4.25M – 263
2022
Q2 		$4.25M Sell
177,272
-174,410
-50% -$7.79M 0.03% 151
2022
Q1 		$32.7M Buy
351,682
+266,928
+315% +$23.2M 0.14% 86
2021
Q4 		$8.08M Buy
+84,754
New +$11.6M 0.02% 156

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ARK Investment Management's BNR Position: Q3 2022 in Review

ARK Investment Management sold out of Burning Rock Biotech (BNR) in Q3 2022, closing a stake of 177,272 shares — an estimated $4.25M sold.

ARK Investment Management first reported a position in BNR in Q4 2021 and held it in 3 quarters. The position peaked at $32.7M in Q1 2022. 52 funds tracked by Wall St. Rank hold BNR as of Q3 2022.

  • ARK Investment Management reported no remaining Burning Rock Biotech position as of Q3 2022 after selling out during the quarter.
  • ARK Investment Management sold 177,272 Burning Rock Biotech shares in Q3 2022, an estimated $4.25M.
  • ARK Investment Management first reported a position in Burning Rock Biotech in Q4 2021 and held it in 3 quarters.
  • ARK Investment Management's Burning Rock Biotech position peaked at $32.7M in Q1 2022.
  • 52 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2022.

Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.